WORK Medical (WOK) Technology entered into an investment agreement with Neologics Bioscience to invest $1M in cash to acquire a 10% equity interest in Neologics. Pursuant to the Investment Agreement, ...
What To Know: The Hunan Provincial Medical Products Administration approved manufacturing for Work Medical’s Class II medical device, an artificial intelligence automated human blood cell morphology ...
Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (WOK) (“WORK Medical”, the “Company” or “we”), a supplier of medical devices in China, through its subsidiary, Work ...
Hangzhou, China, Oct. 10, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, ...
This press release contains forward-looking statements, including statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results